GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Tuesday, 19 Aug 2014 | 6:09 PM ET

    Baxter International Inc. fell$. 08 or. 1 percent, to $75.13. Bristol-Myers Squibb Co. rose$. 31 or. 6 percent, to $50.30. Hospira fell $1.56 or 2.8 percent, to $53.92.

  • Midday Glance: Pharmaceuticals companies Tuesday, 19 Aug 2014 | 4:03 PM ET

    Baxter International Inc. rose$. 01 or percent, to $75.22. Bristol-Myers Squibb Co. fell$. 15 or. 3 percent, to $49.84. Hospira fell $1.18 or 2.1 percent, to $54.30.

  • Final Glance: Pharmaceuticals companies Monday, 18 Aug 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 80 or 1.1 percent, to $75.21. Bristol-Myers Squibb Co. rose$. 31 or. 6 percent, to $49.99. Hospira rose$. 46 or. 8 percent, to $55.48.

  • Diversified U.S. manufacturer 3 M Co and medical equipment makers CareFusion Corp and C.R. Bard Inc are among the companies exploring a potential deal for ConvaTec, the people said. CareFusion, with a market capitalization of $9 billion, and C.R. Bard, with $11.2 billion, would both be able to achieve an inversion if they use their own stock to pay for ConvaTec.

  • Early Glance: Pharmaceuticals companies Monday, 18 Aug 2014 | 10:29 AM ET

    Baxter International Inc. rose$. 81 or 1.1 percent, to $75.22. Bristol-Myers Squibb Co. rose$. 13 or. 3 percent, to $49.81. Hospira rose$. 76 or 1.4 percent, to $55.78.

  • Final Glance: Pharmaceuticals companies Friday, 15 Aug 2014 | 6:16 PM ET

    Baxter International Inc. fell$. 34 or. 5 percent, to $74.41. Bristol-Myers Squibb Co. fell$. 14 or. 3 percent, to $49.68. Hospira fell$. 69 or 1.2 percent, to $55.02.

  • Midday Glance: Pharmaceuticals companies Friday, 15 Aug 2014 | 1:15 PM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $74.21. Bristol-Myers Squibb Co. fell$. 33 or. 7 percent, to $49.49. Hospira fell$. 90 or 1.6 percent, to $54.81.

  • Early Glance: Pharmaceuticals companies Thursday, 14 Aug 2014 | 10:33 AM ET

    Baxter International Inc. fell$. 23 or. 3 percent, to $74.73. Bristol-Myers Squibb Co. rose$. 60 or 1.2 percent, to $49.77. Hospira fell$. 07 or. 1 percent, to $55.09.

  • Final Glance: Pharmaceuticals companies Wednesday, 13 Aug 2014 | 6:14 PM ET

    Baxter International Inc. rose$. 69 or. 9 percent, to $74.96. Bristol-Myers Squibb Co. rose$. 19 or. 4 percent, to $49.17. Hospira rose$. 62 or 1.1 percent, to $55.16.

  • Midday Glance: Pharmaceuticals companies Wednesday, 13 Aug 2014 | 1:50 PM ET

    Baxter International Inc. rose$. 61 or. 8 percent, to $74.88. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $49.37. Hospira rose$. 48 or. 9 percent, to $55.02.

  • Early Glance: Pharmaceuticals companies Tuesday, 12 Aug 2014 | 12:14 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $74.04. Bristol-Myers Squibb Co. fell$. 01 or percent, to $49.09. Pfizer fell$. 01 or percent, to $28.24.

  • Final Glance: Pharmaceuticals companies Monday, 11 Aug 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 30 or. 4 percent, to $74.20. Bristol-Myers Squibb Co. fell$. 10 or. 2 percent, to $49.09. Hospira rose$. 19 or. 3 percent, to $54.57.

  • Midday Glance: Pharmaceuticals companies Monday, 11 Aug 2014 | 1:26 PM ET

    Baxter International Inc. rose$. 67 or. 9 percent, to $74.57. Bristol-Myers Squibb Co. rose$. 21 or. 4 percent, to $49.40. Johnson& Johnson rose$. 21 or. 2 percent, to $101.29.

  • Final Glance: Pharmaceuticals companies Friday, 8 Aug 2014 | 6:06 PM ET

    Baxter International Inc. rose$. 13 or. 2 percent, to $73.90. Bristol-Myers Squibb Co. rose$. 54 or 1.1 percent, to $49.19. Hospira rose$. 76 or 1.4 percent, to $54.38.

  • Midday Glance: Pharmaceuticals companies Friday, 8 Aug 2014 | 1:51 PM ET

    Baxter International Inc. rose$. 10 or. 1 percent, to $73.87. Bristol-Myers Squibb Co. rose$. 25 or. 5 percent, to $48.90. Hospira rose$. 31 or. 6 percent, to $53.93.

  • Early Glance: Pharmaceuticals companies Friday, 8 Aug 2014 | 10:51 AM ET

    Baxter International Inc. fell$. 38 or. 5 percent, to $73.39. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $48.54. Hospira fell$. 12 or. 2 percent, to $53.50.

  • Why dying kids can't get the drugs they need Tuesday, 5 Aug 2014 | 7:33 AM ET
    Nathalie Traller back in the clinic.

    Terminally ill patients are increasingly seeking access experimental drugs outside clinical trials, but drug companies often decline these requests. A look at why.

  • AstraZeneca steps up push into cancer immunotherapy Thursday, 31 Jul 2014 | 8:51 AM ET

    LONDON, July 31- AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumor types. AstraZeneca said it would present further data looking at MEDI4736 in lung cancer, as well as early results for head and neck cancer, in September at the annual meeting of the European Society for Medical Oncology.

  • NEW YORK, July 28- Pfizer Inc's vulnerability to cheaper generics and its weak roster of experimental medicines will be on display Tuesday when the company reports quarterly earnings, reviving interest in its pursuit of AstraZeneca Plc or other deals to fortify its pipeline.

  • July 24- Bristol-Myers Squibb Co reported better-than-expected quarterly results, helped by cost controls and strong sales of its Eliquis blood clot preventer and Yervoy treatment for melanoma. Sales of Eliquis, which Bristol-Myers co-markets with Pfizer Inc, rose to $171 million.